Note: Ingredients listed on restricted chemical lists
EC/CAS
231-847-6/7758-99-8
Name of the chemical
Copper sulphate pentahydrate
Concentration
10 - 20
General Information
Version
1.3
Revision date
2024-12-17
Product name
Kjeldahl catalyst tablets
CAS No.
7758-98-7
1.2.1 Relevant identified uses
Laboratory use
Emergency telephone
+34 937 077 970, 0344 892 0111, +34 91 5620420
Icons in SDS
Company Information
company name
labbox labware s.l
e-mail address of the competent person responsible for the Safety Data Sheet
info@labbox.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H318, H400, H410
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
No additional information available
Hazard pictograms
GHS07 GHS05 GHS09
Signal word
Danger
Contains
copper sulphate pentahydrate
Hazard statements
H302 - Harmful if swallowed. H318 - Causes serious eye damage. H410 - Very toxic to aquatic life with long lasting effects.
Precautionary statements
P273 - Avoid release to the environment. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 - Immediately call a POISON CENTER or doctor. P391 - Collect spillage. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.
PBT Substances
not relevant – no registration required Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Acute toxicity (oral), Category 4 H302 Serious eye damage/eye irritation, Category 1 H318 Hazardous to the aquatic environment — Acute Hazard, H400 Category 1 Hazardous to the aquatic environment — Chronic Hazard, H410 Category 1 Full text of H and EUH statements: see section 16 Adverse physicochemical, human health and environmental effects No additional information available
